Stephen Mayo

Insider Reports History

Entity
Individual
Location
2000 Galloping Hill Rd, Kenilworth, NJ
Signature
/s/Stephen Mayo
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen Mayo:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Merck & Co., Inc. Director Phantom Stock 9.38K $1.18M $125.54 May 31, 2024 Direct
Sarepta Therapeutics, Inc. Director Common Stock 6.62K $814K $122.96 Mar 5, 2024 Direct
Allogene Therapeutics, Inc. Director Common Stock 25.3K $80.4K $3.17 Aug 7, 2023 Direct
Merck & Co., Inc. Director Common Stock 100 $12.8K $127.51 May 31, 2024 Direct
Allogene Therapeutics, Inc. Director Stock Option (Right to buy) 191K Jun 5, 2024 Direct
Sarepta Therapeutics, Inc. Director Stock Option (right to buy) 3.68K Mar 1, 2024 Direct

Insider Reports Filed by Stephen Mayo

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALLO Allogene Therapeutics, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
MRK Merck & Co., Inc. May 31, 2024 1 $220K 4 Jun 4, 2024 Director
SRPT Sarepta Therapeutics, Inc. Mar 5, 2024 1 -$385K 4 Mar 6, 2024 Director
SRPT Sarepta Therapeutics, Inc. Mar 1, 2024 2 $0 4 Mar 5, 2024 Director
ALLO Allogene Therapeutics, Inc. Aug 7, 2023 1 -$42.9K 4 Aug 9, 2023 Director
ALLO Allogene Therapeutics, Inc. Jun 13, 2023 1 $0 4 Jun 15, 2023 Director
MRK Merck & Co., Inc. May 26, 2023 1 $220K 4 May 31, 2023 Director
SRPT Sarepta Therapeutics, Inc. Mar 6, 2023 2 $0 4 Mar 8, 2023 Director
SRPT Sarepta Therapeutics, Inc. Nov 17, 2022 1 -$94.3K 4 Nov 21, 2022 Director
ALLO Allogene Therapeutics, Inc. Jul 8, 2022 2 $0 4 Jul 12, 2022 Director
ALLO Allogene Therapeutics, Inc. Jul 8, 2022 0 $0 3 Jul 12, 2022 Director
MRK Merck & Co., Inc. May 27, 2022 1 $220K 4 Jun 1, 2022 Director
SRPT Sarepta Therapeutics, Inc. Mar 7, 2022 2 $0 4 Mar 9, 2022 Director
SRPT Sarepta Therapeutics, Inc. Nov 16, 2021 2 $0 4 Nov 17, 2021 Director
SRPT Sarepta Therapeutics, Inc. Nov 16, 2021 0 $0 3 Nov 17, 2021 Director
MRK Merck & Co., Inc. May 28, 2021 1 $200K 4 Jun 2, 2021 Director